WITH many countries reopening their borders as the Covid-19 pandemic recedes due to increasing vaccination worldwide, medical tourism by patients seeking IVF (in vitro fertilisation) procedures banned in their home countries but available abroad, is once again on the rise.
One of the most controversial of these is sex selection by genetic testing of IVF embryos, a procedure known as preimplantation genetic screening (PGS) or preimplantation genetic testing-aneuploidy (PGT-A).
Subscribe now to our Premium Plan for an ad-free and unlimited reading experience!
